<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02018159</url>
  </required_header>
  <id_info>
    <org_study_id>000102</org_study_id>
    <nct_id>NCT02018159</nct_id>
  </id_info>
  <brief_title>An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferring Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-marketing, multi-center prospective study will be conducted in a open-label,
      non-interventional setting, for women seeking fertility treatment and will describe
      morphokinetic de-selection parameters in human embryos.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">May 12, 2016</completion_date>
  <primary_completion_date type="Actual">February 12, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of direct cleavage from 1 to 3 and from 2 to 5 cells</measure>
    <time_frame>1 week after oocyte retrieval</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of uneven blastomeres at the 2 and 4 cell stage</measure>
    <time_frame>1 week after oocyte retrieval</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of bi- and multinucleation at 2 cell and 4 cell stage</measure>
    <time_frame>1 week after oocyte retrieval</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Smooth Endoplasmatic Reticulum at the Metaphase II stage, the Pro Nuclei stage and the 2, 3 and 4 cell stage</measure>
    <time_frame>1 week after oocyte retrieval</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive serum human Chorion Gonadotrophin (hCG) rate</measure>
    <time_frame>13-15 days after transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>5 weeks after transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>7 weeks after transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>10 weeks after transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">738</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Women treated with Menopur</arm_group_label>
    <description>Women treated with Menopur can participate with more than one cycle. 700 cycles will be enrolled.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>menotropin</intervention_name>
    <arm_group_label>Women treated with Menopur</arm_group_label>
    <other_name>Menopur</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women seeking fertility treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21-45 years

          -  In Vitro Fertilisation/Intra Cytoplasmic Sperm Injection treatment in long or short
             protocol

          -  Receiving follicle stimulation with Menopur 600/1200 IU
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Development Support</last_name>
    <role>Study Director</role>
    <affiliation>Ferring Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fertilitetsklinikken Hospitalsenheden Horsens, Regionshospitalet Horsens (there may be other sites in this country)</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2013</study_first_posted>
  <last_update_submitted>August 25, 2017</last_update_submitted>
  <last_update_submitted_qc>August 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menotropins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

